Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
tPA for MicroCLOTS in COVID-19 ARDS
NCT04453371Phase 3Withdrawn
- Sponsor
- Negovsky Research Institute of General Reanimatology
- Start
- Oct 2020
- Primary completion
- Jan 2021
- Modality
- rProtein (Recombinant Protein), Biologic
01
Overview
A Phase 3 trial of tissue-plasminogen activator in coronavirus disease 2019 (COVID-19), acute respiratory distress syndrome (ARDS), sponsored by Negovsky Research Institute of General Reanimatology. Planned start Oct 2020; status: withdrawn.
02
Drugs
tissue-plasminogen activator
03
Conditions
coronavirus disease 2019 (COVID-19)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04453371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04453371.